Movicol Med Sjokoladesmak

Macrogol 3350 with electrolytes, the active ingredient in Movicol Med Sjokoladesmak, is an osmotic laxative presented as an oral powder for oral administration. It creates an osmotic gradient that retains water in the intestinal lumen, softening stool and facilitating regular bowel movements, and is used to relieve constipation in both adult and paediatric patients.

GNH USA supplies Movicol Med Sjokoladesmak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for this essential constipation therapy.

Movicol Med Sjokoladesmak, an osmotic laxative, is used to manage conditions characterized by difficult stool passage. - Constipation: softens stool and increases bowel frequency to relieve occasional or chronic constipation. - Chronic idiopathic constipation: provides sustained stool softening for long‑term management. - Opioid‑induced constipation: counteracts reduced gastrointestinal motility caused by opioid therapy.

Common and serious adverse reactions have been reported with osmotic laxatives such as Movicol Med Sjokoladesmak.

Common Side Effects: - Abdominal bloating: sensation of fullness in the abdomen. - Nausea: mild to moderate feeling of sickness. - Flatulence: increased intestinal gas. - Diarrhoea: loose stools occurring more frequently.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching or swelling. - Severe abdominal pain: intense, persistent pain.

When prescribing Movicol Med Sjokoladesmak, consider the following precautions to ensure safe use. - Renal function assessment: evaluate kidney function before initiating therapy. - Electrolyte monitoring: check serum electrolytes periodically, especially in high‑risk patients. - Bowel obstruction: avoid use in patients with known or suspected intestinal blockage. - Elderly dosing: start with the lowest effective dose in older adults. - Concomitant diuretics: use caution as combined effect may alter fluid balance. - Store at ambient temperature: keep in original packaging, protect from moisture and excessive heat.

Movicol Med Sjokoladesmak may interact with other medicines; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Other osmotic laxatives: concurrent use can cause severe diarrhoea and electrolyte loss. - High‑dose potassium supplements: may lead to hyperkalaemia when combined with the product’s potassium content. - Loop diuretics: increased risk of electrolyte disturbances and dehydration.

Moderate Interactions (Monitor Closely): - Antacids containing sodium or potassium: may affect electrolyte balance and require monitoring. - ACE inhibitors or ARBs: combined use can increase the chance of hyperkalaemia.